Drugs of the Future Journal Citation Rate 2026

ISSN 0377-8282 eISSN 2013-0368 Thomson Reuters ES

About Drugs of the Future
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Drugs of the Future (DF) is a peer-reviewed academic journal, published by Thomson Reuters in ES, catalogued under ISSN 0377-8282 (e-ISSN 2013-0368). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 0.00 — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model.

ISSN (Print) 0377-8282
ISSN (Online) 2013-0368
Publisher Thomson Reuters
Country Spain
APC / Cost Inquire with Publisher
h-index 49
Total Works 6,527
Total Citations 21,360
In-depth profile & metrics

Drugs of the Future is published by Thomson Reuters and based in Spain.

Editorially, Drugs of the Future concentrates on Cancer Treatment and Pharmacology, Drug-Induced Ocular Toxicity and Drug-Induced Adverse Reactions, within the broader field of Medicine.

Drugs of the Future is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

OpenAlex records 6,527 works that have together drawn 21,360 citations, giving the journal an h-index of 49.

Links
Frequently Asked Questions about Drugs of the Future

No, Drugs of the Future is not an open access journal.

Drugs of the Future is published by Thomson Reuters.

Drugs of the Future shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Drugs of the Future is 0377-8282. Its electronic ISSN (eISSN) is 2013-0368.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
0.000
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 0.000 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.


Works Published per Year (2012–2023)

Annual publication volume sourced from OpenAlex. Current year omitted (partial data).

Publication & citation history by year
YearWorks publishedCitations received
2023 25 19
2022 101 37
2021 108 53
2020 93 105
2019 105 87
2018 111 78
2017 94 74
2016 99 78
2015 156 95
2014 232 84
2013 224 380
2012 227 283
Journal at a Glance
6,527
Total Works
21,360
Total Citations
49
h-index

Source: OpenAlex — refreshed daily.

Top Research Topics

The areas where Drugs of the Future most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.

252 works
180 works
Blood disorders and treatments
Biochemistry, Genetics and Molecular Biology
159 works
Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S154339661

Get weekly updates

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google